Lunai Bioworks (LNAI) Assets Average (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Assets Average of $8.3 million in Q1 2026, up 21.28% quarter-over-quarter from $6.8 million in Q4 2025, and down 92.79% on a YoY basis from $114.5 million in Q1 2025.
Lunai Bioworks (LNAI) Assets Average (2011 - 2026) Analysis & Trends
Lunai Bioworks' Assets Average history runs 16 years deep, the most recent figure standing at $8.3 million for Q1 2026.
- In Q1 2026, Assets Average fell 92.79% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (down 92.79% YoY), while the FY2025 annual figure was $85.7 million, down 22.61% from the prior year.
- Assets Average was $8.3 million for Q1 2026 at Lunai Bioworks, up from $6.8 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $181.6 million in Q1 2022 to a low of $6.8 million in Q4 2025.
- Historically, Assets Average has averaged $87.7 million across 5 years, with a median of $81.7 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Assets Average soared 149.01% in 2024, then sank 94.67% in 2025.
- A 5-year view of Assets Average shows it stood at $81.7 million in 2022, then slipped by 29.24% to $57.8 million in 2023, then jumped by 101.74% to $116.6 million in 2024, then sank by 94.16% to $6.8 million in 2025, then gained by 21.28% to $8.3 million in 2026.
- The last three Assets Average figures came in at $8.3 million (Q1 2026), $6.8 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 8.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.26 Mn |
| Dec 31, 2025 | 6.81 Mn |
| Sep 30, 2025 | 7.60 Mn |
| Jun 30, 2025 | 62.98 Mn |
| Mar 31, 2025 | 114.53 Mn |
| Dec 31, 2024 | 116.59 Mn |
| Sep 30, 2024 | 142.48 Mn |
| Jun 30, 2024 | 170.61 Mn |
| Mar 31, 2024 | 118.05 Mn |
| Dec 31, 2023 | 57.79 Mn |
| Sep 30, 2023 | 57.93 Mn |
| Jun 30, 2023 | 68.52 Mn |
| Mar 31, 2023 | 79.50 Mn |
| Dec 31, 2022 | 81.67 Mn |
| Sep 30, 2022 | 83.85 Mn |
| Jun 30, 2022 | 132.37 Mn |
| Mar 31, 2022 | 181.62 Mn |
| Dec 31, 2021 | 183.60 Mn |
| Sep 30, 2021 | 186.83 Mn |
| Jun 30, 2021 | 181.65 Mn |